Mimedix
-
MiMedx Group Announces Proposed $5,000,000 Private Placement
MARIETTA, Ga., Sept. 29 /PRNewswire-FirstCall/ — MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based…
Read More » -
MiMedx Receives FDA Clearance to Market Additional HydroFix™ Vaso Shield Device Configurations
MARIETTA, Ga., June 7 /PRNewswire/ — MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected…
Read More » -
MiMedx Group Announces First Quarter Results
MARIETTA, Ga., April 27, 2010 /PRNewswire via COMTEX/ — MiMedx Group, Inc.(MDXG 1.49, +0.14, +10.37%) announced today its financial results for the first…
Read More » -
MiMedx Group Announces CE Mark for the HydroFix(TM) Spine Shield
ATLANTA, March 1 /PRNewswire-FirstCall/ — MiMedx Group, Inc. (OTC Bulletin Board: MDXG) announced today that the Company received the CE Mark for…
Read More » -
Biotech firm to raise $10M
The company, which went public (OTCBB: MDXG) through a reverse merger in February 2008, plans to raise an initial $5…
Read More »